Latest Equity Participation News

Terragen Holdings secures a landmark supply agreement for its probiotic and biostimulant products with Ravensworth Feedlot, alongside a $2.8 million funded trial at Mort & Co’s Grassdale feedlot to validate its probiotic’s impact on cattle performance.

Nexalis Therapeutics has locked in a $53 million non-dilutive funding facility with Point8 Capital, replacing its previous lender and supporting three clinical programs targeting breakthrough cancer pain, panic disorder, and treatment-resistant depression.

Jameson Resources has cleared a major environmental hurdle for its Crown Mountain steelmaking coal project, receiving the Section 27 Notice from British Columbia regulators and setting the stage for final application submission in October 2026.

Tivan Limited has formalised binding joint venture agreements with Timor-Leste’s state-owned Murak Rai Timor to develop the Baucau and Ossu copper-gold projects, targeting maiden drilling at Ossu in late 2026.

PMET Resources has secured crucial non-binding letters of support from Export Development Canada and Germany’s KfW IPEX-Bank, marking a key step toward financing its Shaakichiuwaanaan critical minerals project in Quebec ahead of an updated feasibility study.

KGL Resources has locked in a US$300 million streaming agreement with Wheaton Precious Metals, marking a pivotal step in funding the Jervois Copper Project in Australia's Northern Territory. This deal provides significant upfront capital without traditional debt constraints, positioning KGL for copper production growth.

Orion Minerals secures a major milestone as South Africa’s IDC converts its loan into a significant equity stake in the Prieska Project, streamlining financing and advancing development plans.

Dome Gold Mines Ltd launches a $3 million convertible note offering to fund key developments in Fiji, including the Sigatoka Feasibility Study and expanded exploration for copper, gold, and silver.

Pacific Lime and Cement Limited has formalised a landmark agreement with the Papua New Guinea government to develop the country’s first integrated lime and cement manufacturing platform, marking a major step in PNG’s industrial growth.

Avecho Biotechnology reported a 9.3% revenue increase alongside a 41.5% rise in net loss for 2025, while progressing its Phase III CBD insomnia trial and securing a significant licensing agreement with Sandoz.

Auravelle Metals has appointed seasoned geologist Stephen Biggins as Non-Executive Chair, marking a strategic leadership shift as the company advances its high-grade gold projects in South Australia and Western Australia.

Pharmx Technologies has entered a multi-year strategic alliance with Sigma Healthcare, becoming the preferred EDI provider for Sigma and Chemist Warehouse across Australia and New Zealand, while Sigma takes a significant equity stake.